3-Methylimidazo[1,2-a]pyridine-7-carbonitrile

Catalog No. :
ACNFKE680
CAS No. :
952511-37-4
Molecular Formula :
C9H7N3
Molecular Weight :
157.18

IUPAC Name:3-methylimidazo[1,2-a]pyridine-7-carbonitrile

3-Methylimidazo[1,2-a]pyridine-7-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$309.00Login to see priceIn stockInquiry
250mg95%$515.00Login to see priceIn stockInquiry
500mg95%$859.00Login to see priceIn stockInquiry
1g95%$1288.00Login to see priceIn stockInquiry
5g95%$3863.00Login to see priceInquiryInquiry
10g95%$6438.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Methylimidazo[1,2-a]pyridine-7-carbonitrile
IUPAC Name3-methylimidazo[1,2-a]pyridine-7-carbonitrile
MDL No.MFCD20527664
Molecular FormulaC9H7N3
Molecular Weight157.18
SMILESN#CC1=CC2=NC=C(C)N2C=C1
InChI KeyNPXDHARGEFFOLL-UHFFFAOYSA-N
Synonym3-methylimidazo[1,2-a]pyridine-7-carbonitrile | 952511-37-4 | SCHEMBL12618989 | MFCD20527664 | SB16200 | CS-0309666 | imidazo[1,2-a]pyridine-7-carbonitrile,3-methyl-
CAS No.952511-37-4
PubChem CID59214393

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACNFKE680 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNFKE680 route product structure diagram
    ACNFKE680952511-37-4 In Stock
Inquiry

2. ACNFKE680 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACNFKE680 route product structure diagram
    ACNFKE680952511-37-4 In Stock
Inquiry

Comments (0)